FDA Halts Sarepta’s Gene Therapy Trials After Deaths; Platform Designation Revoked Amid Safety Concerns

The U.S. Food and Drug Administration announced it has placed Sarepta Therapeutics investigational gene therapy clinical trials for limb girdle muscular ...

July 21, 2025 | Monday | Regulatory
10x Genomics and A*STAR GIS Launch Landmark Spatial Biology Study in Asia to Drive Cancer and Inflammation Breakthroughs

Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases 10x Gen...

July 18, 2025 | Friday | News
Quetzal Therapeutics Launches with $50 Million to Advance Treatments for Rare and Life-Threatening Diseases

Quetzal Therapeutics, a newly formed biopharmaceutical company, announced its official launch with $50 million of committed capital. Founded to address u...

July 17, 2025 | Thursday | News
Amphista Therapeutics Reaches Discovery Milestone in Merck Collaboration for Next-Gen Protein Degraders

Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery of next-generation, Targeted Protein Degradation (...

July 17, 2025 | Thursday | News
Acumen and JCR Pharmaceuticals Partner to Develop Enhanced Brain Delivery Therapy for Alzheimer’s Disease

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a ...

July 16, 2025 | Wednesday | News
Addgene and Promega Launch Plasmid Collection to Accelerate Drug Discovery Research

Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed, and reproducibility,  announced a strategic ...

July 16, 2025 | Wednesday | News
CARsgen Secures Final EPO Win for GPC3 CAR-T Patent After Appeal Withdrawal

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces a favorable outco...

July 14, 2025 | Monday | News
Secarna and Vect-Horus Join Forces to Unlock RNA Therapeutics for CNS Disorders

  The partnership combines Secarna’s OligoCreator® technology with Vect-Horus’ VECTrans® platform to enable system...

July 11, 2025 | Friday | News
Hongene Biotech Powers IND-Cleared siRNA Therapy DNV001 with End-to-End CDMO Capabilities

Hongene Biotech Corporation, a contract development and manufacturing organization (CDMO) specializing in nucleic acid therapeutics,  announced its ...

July 11, 2025 | Friday | News
Zhimeng Biopharma Receives CDE Approval to Advance CB03-154 into Phase 2/3 Trials for ALS in China

Shanghai Zhimeng Biopharma, Inc. ("Zhimeng Biopharma"), a clinical-stage biopharmaceutical company dedicated to innovative drug development for liver and...

July 10, 2025 | Thursday | News
Purespring Therapeutics Receives FDA Clearance to Initiate Clinical Trials for IgA Nephropathy Gene Therapy

Purespring Therapeutics, a precision nephrology company focused on transforming the treatment of kidney diseases, announces that the U.S. Food and Drug A...

July 10, 2025 | Thursday | News
Longeveron Receives FDA Clearance to Begin Phase 2 Trial of Stem Cell Therapy for Pediatric Dilated Cardiomyopathy

 Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and...

July 09, 2025 | Wednesday | News
Amarna Therapeutics and NorthX Biologics Advance Gene Therapy Manufacturing for Type 1 Diabetes

Amarna Therapeutics, (“Amarna” or “the Company”), a privately held biotechnology company pioneering transformative gene therapies...

July 09, 2025 | Wednesday | News
Johnson & Johnson Submits EMA Application to Broaden AKEEGA® Use in HRR‑Mutated Metastatic Hormone‑Sensitive Prostate Cancer

The submission is based on results from the Phase 3 AMPLITUDE study evaluating niraparib in combination with abiraterone acetate plus prednisone or predn...

July 07, 2025 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close